Summary: This study evaluated the safety and effectiveness of ivaroxaban-aspirin combination therapy in secondary prevention of major adverse cardiovascular events in Chinese patients with stable cardiovascular diseases.

Summary: This article discusses the use of dual antiplatelet therapy after stenting for the treatment of patients with peripheral artery disease.

Summary: This article discusses the use of cilostazol for secondary stroke prevention in patients with stroke.

Summary: The aim of the study was to compare effectiveness and safety of treatments used in patients with peripheral artery disease undergoing peripheral revascularization accounting.

Summary: This study compared the effects of maximal and submaximal walking for patients with peripheral artery disease (PAD).

Summary: This review of the literature investigated the outcomes of statin therapy in the treatment of patients with peripheral artery disease (PAD).

Summary: This review of literature evaluated the effectiveness and safety of Xa inhibitors (blood thinning drugs) in patients with heart failure (HF) and coronary artery disease (when the major blood vessels that supply the heart become damaged or diseased; CAD) or peripheral artery disease (narrowed arteries reduce blood flow to the limbs; PAD).

Summary: This study investigated changes in the use of cardioprotective medication in the treatment of patients with peripheral artery disease (PAD).

Summary: A Case of Massive Lower Gastrointestinal Bleed from a Cystic Artery Pseudoaneurysm Bleeding through a Cholecystocolic Fistula.

Summary: This study reported the effects of rivaroxaban plus aspirin in the treatment of patients with chronic coronary or peripheral artery disease (PAD).

Summary: Cilostazol for intermittent claudication.

Summary: This study compared the outcomes of intravascular lithotripsy (IVL) for the treatment of patients with peripheral artery calcification.